These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 25704014)

  • 21. Neuronal injury in chronic CNS inflammation.
    Zindler E; Zipp F
    Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Linkage between immunomodulation, neuroprotection and neurogenesis.
    Aharoni R; Arnon R
    Drug News Perspect; 2009; 22(6):301-12. PubMed ID: 19771319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroprotective role of polyphenols against oxidative stress-mediated neurodegeneration.
    Uddin MS; Al Mamun A; Kabir MT; Ahmad J; Jeandet P; Sarwar MS; Ashraf GM; Aleya L
    Eur J Pharmacol; 2020 Nov; 886():173412. PubMed ID: 32771668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Catechin polyphenols: neurodegeneration and neuroprotection in neurodegenerative diseases.
    Mandel S; Youdim MB
    Free Radic Biol Med; 2004 Aug; 37(3):304-17. PubMed ID: 15223064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of glial cells in Alzheimer disease: potential therapeutic implications.
    Lopategui Cabezas I; Herrera Batista A; Pentón Rol G
    Neurologia; 2014 Jun; 29(5):305-9. PubMed ID: 23246214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protease-activated receptors in the brain: receptor expression, activation, and functions in neurodegeneration and neuroprotection.
    Luo W; Wang Y; Reiser G
    Brain Res Rev; 2007 Dec; 56(2):331-45. PubMed ID: 17915333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurosteroids and sigma1 receptors, biochemical and behavioral relevance.
    Maurice T
    Pharmacopsychiatry; 2004 Nov; 37 Suppl 3():S171-82. PubMed ID: 15547783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. On the hypes and falls in neuroprotection: targeting the NMDA receptor.
    Villmann C; Becker CM
    Neuroscientist; 2007 Dec; 13(6):594-615. PubMed ID: 17911221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perspectives of drug-based neuroprotection targeting mitochondria.
    Procaccio V; Bris C; Chao de la Barca JM; Oca F; Chevrollier A; Amati-Bonneau P; Bonneau D; Reynier P
    Rev Neurol (Paris); 2014 May; 170(5):390-400. PubMed ID: 24792485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dextromethorphan protects dopaminergic neurons against inflammation-mediated degeneration through inhibition of microglial activation.
    Liu Y; Qin L; Li G; Zhang W; An L; Liu B; Hong JS
    J Pharmacol Exp Ther; 2003 Apr; 305(1):212-8. PubMed ID: 12649371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Astrogliosis as a therapeutic target for neurodegenerative diseases.
    Colangelo AM; Alberghina L; Papa M
    Neurosci Lett; 2014 Apr; 565():59-64. PubMed ID: 24457173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of the blood brain barrier in neurodegenerative disorders and their treatment.
    Palmer AM
    J Alzheimers Dis; 2011; 24(4):643-56. PubMed ID: 21460432
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multifunctional activities of green tea catechins in neuroprotection. Modulation of cell survival genes, iron-dependent oxidative stress and PKC signaling pathway.
    Mandel SA; Avramovich-Tirosh Y; Reznichenko L; Zheng H; Weinreb O; Amit T; Youdim MB
    Neurosignals; 2005; 14(1-2):46-60. PubMed ID: 15956814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Down-regulation of microglial activation may represent a practical strategy for combating neurodegenerative disorders.
    McCarty MF
    Med Hypotheses; 2006; 67(2):251-69. PubMed ID: 16513287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sigma-1 receptor agonists provide neuroprotection against gp120 via a change in bcl-2 expression in mouse neuronal cultures.
    Zhang Y; Shi Y; Qiao L; Sun Y; Ding W; Zhang H; Li N; Chen D
    Brain Res; 2012 Jan; 1431():13-22. PubMed ID: 22133307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sigma-1 receptor: the novel intracellular target of neuropsychotherapeutic drugs.
    Hayashi T
    J Pharmacol Sci; 2015 Jan; 127(1):2-5. PubMed ID: 25704011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Excitatory amino acid transporter expression by astrocytes is neuroprotective against microglial excitotoxicity.
    Liang J; Takeuchi H; Doi Y; Kawanokuchi J; Sonobe Y; Jin S; Yawata I; Li H; Yasuoka S; Mizuno T; Suzumura A
    Brain Res; 2008 May; 1210():11-9. PubMed ID: 18410911
    [TBL] [Abstract][Full Text] [Related]  

  • 38. AMPA receptor regulation mechanisms: future target for safer neuroprotective drugs.
    Jayakar SS; Dikshit M
    Int J Neurosci; 2004 Jun; 114(6):695-734. PubMed ID: 15204061
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impacts of methylxanthines and adenosine receptors on neurodegeneration: human and experimental studies.
    Chen JF; Chern Y
    Handb Exp Pharmacol; 2011; (200):267-310. PubMed ID: 20859800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of Plant-Derived Flavonoids on Neurodegenerative Diseases.
    Costa SL; Silva VD; Dos Santos Souza C; Santos CC; Paris I; Muñoz P; Segura-Aguilar J
    Neurotox Res; 2016 Jul; 30(1):41-52. PubMed ID: 26951456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.